<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>13581062</identifier>
<setSpec>0040-8867</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>PABLOS GUIRAO</dc:author>
<dc:author>ZAMARRIEGO</dc:author>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>CHLORPROMAZINE/therapeutic use</dc:subject>
<dc:subject>OXYTOCIN/therapeutic use</dc:subject>
<dc:subject>FETUS/effect of drugs on</dc:subject>
<dc:subject>PITUITARY GLAND, POSTERIOR/hormones</dc:subject>
<dc:date>1958 Jun-Jul </dc:date>
<dc:title xml:lang="es">Repercusión sobre el feto de pituitrina intravenosa y de la asociación pituitrina-largactil.</dc:title>
<dc:title xml:lang="en">[Effect on the fetus of intravenous pituitrin &amp; combined pituitrin-largactil].</dc:title>
<dc:publisher>Toko-ginecologia practica</dc:publisher>
</metadata>
</record>
</pubmed-document>
